Literature DB >> 1655640

Affinity-purified soluble Fc epsilon RII/CD23 derived from a culture supernatant of an EBV-immortalized B-cell line induced a monophasic fever in rabbits.

A A Ghaderi1, D R Stanworth.   

Abstract

A soluble form of Fc epsilon RII/CD23 is spontaneously released from most lymphoblastoid cell lines established by the Epstein-Barr virus (EBV). Such a product was purified on an IgE-Sepharose column and its pyrogenic effect was investigated in rabbits. This preparation induced a monophasic fever in rabbits, with a peak response appearing 75 min after injection. Since IgE was found to be capable of abrogating such an effect, it is suggested that IgE might be involved in the control of the effectiveness of this soluble protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655640      PMCID: PMC1384586     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Pathogenesis of fever.

Authors:  E ATKINS
Journal:  Physiol Rev       Date:  1960-07       Impact factor: 37.312

2.  Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity.

Authors:  R C Newton
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

3.  Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40).

Authors:  J Cairns; L Flores-Romo; M J Millsum; G R Guy; S Gillis; J A Ledbetter; J Gordon
Journal:  Eur J Immunol       Date:  1988-03       Impact factor: 5.532

4.  Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Wideman; J Y Bonnefoy; J E De Vries
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

5.  Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

Authors:  J Van Damme; M De Ley; G Opdenakker; A Billiau; P De Somer; J Van Beeumen
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

6.  Use of synthetic peptides in the production and characterization of antibodies directed against predetermined specificities in rat immunoglobulin E.

Authors:  D S Burt; G Z Hastings; D R Stanworth
Journal:  Mol Immunol       Date:  1986-02       Impact factor: 4.407

7.  Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.

Authors:  J Y Bonnefoy; T Defrance; C Peronne; C Menetrier; F Rousset; J Pène; J E De Vries; J Banchereau
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

8.  Fever and acute phase response induced in rabbits by human recombinant interferon-gamma.

Authors:  A Morimoto; N Murakami; M Takada; S Teshirogi; T Watanabe
Journal:  J Physiol       Date:  1987-10       Impact factor: 5.182

9.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.

Authors:  D Vercelli; H H Jabara; B W Lee; N Woodland; R S Geha; D Y Leung
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Studies on the mechanism of fever accompanying delayed hypersensitivity. The role of the sensitized lymphocyte.

Authors:  E Atkins; J D Feldman; L Francis; E Hursh
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

View more
  2 in total

Review 1.  CD23: novel disease marker with a split personality.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Regulation of cytokine production by soluble CD23: costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release.

Authors:  M Armant; H Ishihara; M Rubio; G Delespesse; M Sarfati
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.